Contents
HEOR FELLOWSHIP PROGRAM 2024-2026
About Genentech
Considered the founder of the industry, Genentech, now a member of the Roche Group, has been delivering on the promise of biotechnology for over 45 years.
Genentech is a leading biotechnology company that discovers, develops, manufactures and commercializes medicines to treat patients with serious or life-threatening medical conditions. We are among the world’s leading biotech companies, with multiple products on the market and a promising development pipeline.
Our Purpose
We believe it’s urgent to deliver medical solutions right now – even as we develop innovations for the future. We are passionate about transforming patients’ lives. We are courageous in both decision and action. And we believe that good business means a better world.
That is why we come to work each day. We commit ourselves to scientific rigor, unassailable ethics, and access to medical innovations for all. We do this today to build a better tomorrow.
We are proud of who we are, what we do, and how we do it. We are many, working as one across functions, across companies, and across the world.
About The University of Washington
The University of Washington is a world-class leader in health sciences education and has been consistently listed in US News and World Report as one of the top 10 institutions for its graduate programs. The University is particularly noted for its strong research programs and since 1974 has received more federal funds for research and training than any other public university in the United States. It fosters a highly collegial atmosphere between departments and academic units, creating a particularly attractive environment for such partnerships between the public and private sectors.
The Comparative Health Outcomes, Policy & Economics (CHOICE) Institute is housed within the University of Washington School of Pharmacy, which boasts nearly 125 years of academic and research success. Faculty in the program (1) provide advanced research training for graduate students, post-doctoral fellows and clinicians (PharmDs, MDs); (2) conduct rigorous scientific research in economic evaluations and outcomes of pharmaceuticals and other health technologies, and (3) translate and disseminate the results of research into clinical practice and healthcare policy, with the goal of improving patient care.
CHOICE faculty participating in the fellowship have been chosen both for their dedication to teaching and their excellence in research. Each is trained either as a health economist or health services researcher and all have an extensive history of effective economic evaluations and pharmacoepidemiologic research.
University of Washington HEOR Fellowship Faculty
Aasthaa Bansal, PhD
Associate Professor
Douglas Barthold, PhD
Research Assistant Professor, CHOICE Faculty Fellow
Anirban Basu, PhD
Stergachis Family Endowed Director & Professor of Health Economics
Josh Carlson, MPH, PhD
Professor
Beth Devine, PharmD, MBA, PhD, FASHP
Professor Emeritus
Louis P. Garrison, Jr., PhD
Professor Emeritus
Ryan Hansen, PhD, PharmD
Associate Professor & Interim Chair, Department of Pharmacy
Kyu Eun Lee, PhD
Assistant Professor
Jing Li, MA, PhD
Assistant Professor
Sean D. Sullivan, BPharm, PhD
Professor
David L. Veenstra, PharmD, PhD
Professor
A full list of CHOICE Core Faculty, Adjunct Faculty, and Staff can be found here: https://sop.washington.edu/choice/who-we-are/faculty-staff/
A full list of CHOICE Affiliate Faculty can be found here: https://sop.washington.edu/choice/who-we-are/faculty-staff/affiliate-faculty/
Aasthaa Bansal, Ph.D.
Associate Professor
The Comparative Health Outcomes, Policy & Economics (CHOICE) Institute
University of Washington
1959 NE Pacific Ave., H-375-A
Seattle, WA, 98195-7630
abansal@uw.edu
David Veenstra, Pharm.D., Ph.D.
Professor
The Comparative Health Outcomes, Policy & Economics (CHOICE) Institute
University of Washington
1959 NE Pacific Ave., H-375-P
Seattle, WA, 98195-7630
veenstra@uw.edu
Jennifer Whiteley, EdD, MSc., MA
Executive Director of the OMNI Portfolio Evidence for Access
Genentech
1 DNA Way
South San Francisco, CA, 94080
whiteley.jennifer@gene.com
Jan Hansen
Vice President
Emily Cook
Research Management & Application
Gurleen Singh Jhuti
Technical Institute
Jennifer Whiteley
Executive Director of the OMNI Portfolio Evidence for Access
Elaine Yu
HEOR
Jim Zazzali
Health Policy & Systems Research
Emma Behan
UW/Genentech HEOR Fellow 2023-2025
Emma is a recent graduate from the University of Wisconsin School of Pharmacy. She developed an interest in real world evidence after seeing the utility while interning at a healthcare performance consulting firm and completing a health economics outcomes research rotation at the University of Utah. Her research interests include real world evidence, economic modeling, and strategy. Emma looks forward to learning from the distinguished experts at CHOICE and Genentech.
Alexandra Miller
UW/Genentech HEOR Fellow 2023-2025
Alexandra is a recent PharmD/MPH graduate. She developed an interest in health economics and outcomes research while working on Dr. Leticia Moczygemba’s research team throughout her time in pharmacy school at the University of Texas. Her research focused on the value of an ongoing mHealth intervention for the homeless population in Austin with its impact on healthcare utilization trends and patient-reported outcomes. Her research interests include real-world evidence, patient-reported outcomes, and value-based care. During this fellowship, Alexandra is excited about the opportunity to expand her HEOR skills and learn from HEOR experts at the CHOICE Institute and Genentech.
Spencer Cheng
UW/Genentech HEOR Fellow 2022-2024
Spencer received her PharmD from the University of Washington, Seattle (UW) School of Pharmacy. During her first year in this fellowship, Spencer worked with Drs. Aasthaa Bansal and David Veenstra to quantify the productivity loss experienced by patients newly diagnosed with hepatocellular carcinoma (HCC) in a claims database analysis.
In her second year, Spencer joined the Evidence for Access (E4A) team at Genentech, where she continues to work in the oncology space and build on her research interests in health equity. Spencer looks forward to learning from the innovative health economists at Genentech and gain experience in different HEOR projects along the product lifecycle.
Abstracts:
- Cheng, SJ, Bansal, A, Veenstra, D. Defining Colorectal Cancer Recurrence with Structured-Health Data Algorithms: A Targeted Literature Review. ISPOR 2023, May 2023, Boston, MA. (Poster Presentation).
Manuscripts from fellowship:
- Cheng, SJ, Bansal, A, Veenstra, D. Productivity loss by cancer stage in patients newly diagnosed with hepatocellular carcinoma. (In Progress).
Stella Ko
UW/Genentech HEOR Fellow 2022-2024
Stella is a second-year UW/Genentech HEOR Postdoctoral Fellow. She received her PharmD from the University of North Carolina Eshelman School of Pharmacy. She developed an interest in health economics and outcomes research after her research and scholarship in pharmacy (RASP) program during pharmacy school where she was first introduced to outcomes research. Stella’s research interests include cost-effectiveness analysis and real-world evidence. Stella looks forward to working with CHOICE faculties and Genentech team to expand upon her research skills and clinical knowledge while receiving an incredible mentorship from both academic and industry experts.
Abstracts:
- Ko S, Bansal A, Veenstra D. Health State Utility and Quality of Life Measures for Neovascular Age-Related Macular Degeneration. The Professional Society for Health Economics and Outcomes Research 2023. Boston, MA. May 7-10, 2023.
- Ko S, Veenstra D. The Impact of Different Utility Values on a Cost-Effectiveness Model in diabetic Macular Edema. The Professional Society for Health Economics and Outcomes Research 2023. Boston, MA. May 7-10, 2023.
Tommy Majda
UW/Genentech Fellow, 2021 – 2023
PharmD 2021, BS 2015, Creighton University; MS, University of Washington
Thesis: Demographic, Geographic, and Clinical Characteristics Associated with Receipt of Influenza Outpatient Oral Antiviral Treatment in Commercially Insured US Patients: An Exploration of Potential Health Disparities
Current Position: Associate Health Economist, Genentech
Justin Nedzesky
UW/Genentech Fellow, 2021 – 2023
PharmD, BS 2021, Duquesne University; MS, University of Washington
Thesis: Absenteeism associated with gynecologic cancer in the United States
Current Position: Senior Manager, Health Economics and Outcomes Research, Neurocrine Biosciences
Eunice Kim
UW/Genentech Fellow, 2020 – 2022
PharmD 2020, BS 2016, University of Washington; MS, University of Washington
Thesis: Healthcare utilization and expenditures of parents with and without hemophilia A children
Current Position: Associate Health Economist, Genentech
Jenny Yeonhee Park
UW/Genentech Fellow, 2020 – 2022
MS, University of Washington; PharmD 2020, University of Illinois Chicago; BA 2014, University of Chicago
Thesis: Prescribing of Alzheimers Disease Treatments by Provider Type and Geographic Region: A Comparison among Physicians, Nurse Practitioners, and Physician Assistants
Current Position: Associate Director, Health Economics Outcomes Research at Horizon
David Fox
UW/Genentech Fellow, 2019 – 2021
BS, San Francisco State University; PharmD 2019, University of Washington; MS, University of Washington
Thesis: Nusinersen Treatment and Healthcare Costs in Spinal Muscular Atrophy
Current Position: Associate Health Economist- Oncology, Genentech
Samuel Hong
UW/Genentech Fellow, 2019 – 2021
BS 2013, University of California, San Diego; PharmD, 2019, University of Illinois at Chicago; MS, University of Washington
Thesis: The impact of cost sharing on adherence to ibrutinib for patients with diffuse large B-cell lymphoma
Current Position: Director, Global Health Economics & Outcomes Research at Agilent Technologies
Eddie Neuberger
UW/Genentech Fellow, 2018 – 2020
BS 2013, University of Maryland; PharmD 2017, University of Maryland; MBA, 2018, University of Baltimore; MS, University of Washington
Thesis: Evaluating Methods to Estimate United States Multiple Sclerosis Prevalence from Administrative Health Claims Data
Current Position: Senior Manager, Seagen
The University of Washington and Genentech have established a Health Economics and Outcomes Research (HEOR) Fellowship Program. This two-year program will provide formal training and hands-on experience in the HEOR field.
The first year of the program will be spent at the University of Washington (Seattle, WA)
- The fellow will take core courses in biostatistics, health economics, outcomes research, policy, and epidemiology.
- The fellow will be awarded a Master’s Degree from the University upon completion of course requirements and a thesis project.
The second year will be spent at Genentech (South San Francisco, CA)
- The fellow will pursue hands-on training in strategically focused health economics and outcomes to support the commercialization of Genentech’s products.
- The fellow will work closely with colleagues in the Evidence for Access organization, which is comprised of HEOR and Health Systems Researchers, in Genentech’s US Medical Affairs organization.
Application Requirements
- You must hold U.S. citizenship or permanent residency status to apply, we are unable to sponsor non-immigrant visas for this program.
- Degree in pharmacy or health-related discipline.
- Previous research experience (preference will be given to those with a high academic standing).
- Excellent oral and written communication skills, ethics, professionalism, leadership and an interest in the biopharmaceutical industry.
- Curriculum vitae, cover letter, three letters of recommendation.
Selection of fellows will be made by a committee composed of University of Washington faculty members and representatives from the respective company.
Application Process Timeline:
- Eligibility: Degree in Pharmacy by July 1, 2024
- Application Opens: Friday, September 1, 2023
- Application Deadline: Monday, October 23, 2023
- Interview Notification: Monday, October 30, 2023
- Interviews: Week of November 6, 2023 (via Zoom)
- Offer Notification: Rolling, after interviews
- Decision Deadline: December 13, 2023
- Program Start Date: July 1, 2024
How to Apply:
- Login to the Graduate School application: https://apply.grad.uw.edu/portal/gr_app
- Select “Start Graduate Application”
- Complete all sections of the application along the lefthand panel, starting with the Profile Information section.
- Under Program Selection, choose the following:
- Application type: Graduate
- Program: Pharmacy – Health Economics & Outcomes Research (MS)
- Review the Program Requirements and indicate the term and year you intend to enroll in the program
- Select Autumn 2024 (this is when the matriculation to the graduate program would begin).
- For the section, “Application Questions”, select which MS fellowship program(s) to which you would like to apply. You may choose a min. of 1 and a max. of 4. The selections are not ranked.
- Select all that apply: AbbVie Fellowship Program, Bayer Fellowship Program, Genentech Fellowship Program, Seagen Fellowship Program
- To add another program, select “Add a fellowship program”. You may choose up to 4.
- Continue with completing all other sections of the application, including Application Materials and Recommenders.
- Review your application and check for any missing required fields or errors. When ready, click Submit Application. Your application is not submitted until you have paid the application fee.
- Fee waivers are available for those who qualify. Review eligibility requirements and the process for fee waiver requests here: https://grad.uw.edu/prospective-students/how-to-apply/application-fee-waivers/
A more detailed instruction guide can be found here.
Contact Information
For more information, please contact:
Marina Gano, M.Ed.
Graduate Program & Operations Manager
The CHOICE Institute, Department of Pharmacy
206-616-1383
uwsopchoice@uw.edu